As of Q4'25, RXRX reported an operating cash flow of -46.1M USD and a free cash flow of -46.1M USD, marking the lowest negative cash flow figures in the observed period. This represents a significant improvement compared to prior quarters, particularly following the deep troughs seen in Q1'25, where operating and free cash flow reached -132M USD and -134M USD, respectively. Over the period from Q1'23 to Q4'25, both operating and free cash flow for RXRX exhibited substantial volatility, with generally negative values throughout. The data shows pronounced spikes in cash outflows in Q1'24, Q4'24, and Q1'25, followed by notable recoveries in Q2'25 and a marked improvement by Q4'25. While the overall trend remains negative, the sharp reduction in cash outflow by the end of 2025 suggests potential progress in cost management or operational efficiency.